Internal Medicine/Gastronenterology and Hepatology

 

Muhammad Y. Sheikh, MD, FACP, FACG, AGAF

Professor of Clinical Medicine and Surgery, UCSF

 

 

 

 

 

 

 

  Medical School: Dow Medical College
  Residency: Indiana University
  Fellowships: Gastroenterology and Transplant Hepatology, University of Louisville Hospital & Jewish Hospital, Louisville, Kentucky
Clinical Nutrition, Beth Israel Deaconess Hospital, Harvard Medical School, Boston, MA
  Board Certified:

Internal Medicine

Gastroenterology

Physician Nutrition Specialist

  Awards and Recognition:

Recipient ofLaureate Award-2012 “ from American College of Physicians, Northern California Chapter.

  Publications (last 5 years):  
  1. Seronello S, Sheikh MY, Choi J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med. 2007;43:869-82

  2. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C Infection: Molecular Pathways to Metabolic Syndrome. Hepatology 2008; 47:2127-33.

  3. Sheikh MY. Steatosis in Hepatitis C: Mechanisms and Basic Concepts. Current Hepatitis Reports 2008, 7:152–157.

  4. Sheikh MY, Javed U, Singh J, Choudhury J, Deen O, Dhah K, Peterson MW. Bedside Sublingual Video Imaging of Microcirculation in Assessing Bacterial Infection in Cirrhosis. Dig Dis Sci. 2009; 54: 2706–2711.

  5. Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P; Latino Study Group. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med. 2009; 360:257-67

  6. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Rifaximin Treatment in Hepatic Encephalopathy. N Engl J Med. 2010 ;362:1071-81.

  7. Sheikh MY, Mouanoutoua M, Walvick MD, Khang L, Singh J, Stoltz S, Mills PK. Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the San Joaquin Valley. J Community Health. 2011;36:42-6.

  8. Sheikh MY, Mouanoutoua M, Walvick MD, Khang L, Singh J, Stoltz S, Mills PK. Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the SanJoaquin Valley. J Community Health. 2011;36:42-6.

  9. Sheikh MY, Atla PR, Raoufi R, Sadiq H, Sadler PC. Prevalence of Hepatitis B Infection Among Young and Unsuspecting Hmong Blood Donors in the Central California Valley. J Community Health. 2012;37: 181-5..

  10. Sheikh MY, Raoufi R, Atla PR, Riaz M, Oberer C, Moffett MJ. Prevalence of Cirrhosis in Patients with Thrombocytopenia Who Receive Bone Marrow Biopsy.Saudi J Gastroenterol 2012;18:257-62

  11. Wong F, Watson H, Gerbes A, Vilstrup H, Badalamenti S, Bernardi M, Ginès P; {Sheikh MY} Satavaptan Investigators Group}. Satavaptan for management of ascites in cirrhosis. Efficacy and safety across the spectrum of ascites severity Gut. 2012 ;61:108-16.

  12. Sheikh MY, Atla PR, Raoufi R, Sadiq H, Sadler PC Prevalence of hepatitis B infection among young and unsuspecting Hmong blood donors in the Central California Valley. J Community Health. 2012;37:181-5.

  13. Sheikh MY, Atla PR, Ameer A, Sadiq H, Sadler P. Seroprevalence of Hepatitis B and C infections among healthy volunteer blood donors in the Central California Valley. Gutand Liver (Published December, 2012).

  14. Atla PR, Sheikh MY, Mascarenhas R, Choudhury J, Mills P. Survival of patients with hepatocellular carcinoma in the San Joaquin Valley: A comparison with California Cancer Registry data.Ann Gastroenterol 2012; 25: 138-146.

  15. Guthrie J, Sheikh MY, Morrell S, Neal D. A Case-Control Study to Compare the Likelihood of Detecting Liver Disorders Using Coincident Measures of Doppler-Derived Portal Vein Pressure Gradients, Hepatic Venous Waveforms, and the Echogenicity of Liver Parenchyma. Journal of Diagnostic Medical Sonography (JDMS) 2012; 28: 211-221

  16. Harrison SA, Hamzeh FM, Han J, Pandya PK, Sheikh MY, Vierling JM. Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin. Hepatology. 2012;56:464-73

  17. Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C, Palmer M, Levine RA, Bhandari BR, Cornpropst M, Liang W, King B, Mondou E, Rousseau FS, McHutchison J, Chojkier M. A Phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology. 2012;55:419-28

 

 

.